INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NOORINIA R.; SOHEILIAN M.; AZARMINA M.; MONTAHAIE T.; KARIMI S.; BEHDAD B.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2014 | Volume:19 | Issue:2 (75) Page(s): 137-146

Download Full-Text

Persian Verion

View:

803

Download:

Cites:

Information Journal Paper

Title

INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA

Author(s)

Keywords

BEVACIZUMABQ3

DIABETIC MACULAR EDEMAQ3

DIABETIC RETINOPATHYQ3

MACULAR LASER PHOTOCOAGULATIONQ3

TRIAMCINOLONE ACETONIDEQ3

Abstract

Diabetic macular edema (DME) is a leading cause of vision loss in the working-age population worldwide.Numerous early studies suggest an important role for intravitreal anti-VEGF agents such as BEVACIZUMAB in the management of DME. We reviewed manuscripts that had investigated pharmacokinetic, efficacy, safety, dose and frequency of intravitreal BEVACIZUMAB (IVB) injections as well as effect of macular ischemia, initial macular thickness and OCT pattern of DME on the final results of treatment with IVB. In summery literature searches disclosed that almost all studies published up to now provided evidence supporting use of IVB for treatment of either naïve or persistent DME in short and long-term up to two years.

Cites

No record.

References

No record.

Cite

APA: Copy

NOORINIA, R., SOHEILIAN, M., AZARMINA, M., MONTAHAIE, T., KARIMI, S., & BEHDAD, B.. (2014). INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA. BINA, 19(2 (75)), 137-146. SID. https://sid.ir/paper/42752/en

Vancouver: Copy

NOORINIA R., SOHEILIAN M., AZARMINA M., MONTAHAIE T., KARIMI S., BEHDAD B.. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA. BINA[Internet]. 2014;19(2 (75)):137-146. Available from: https://sid.ir/paper/42752/en

IEEE: Copy

R. NOORINIA, M. SOHEILIAN, M. AZARMINA, T. MONTAHAIE, S. KARIMI, and B. BEHDAD, “INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA,” BINA, vol. 19, no. 2 (75), pp. 137–146, 2014, [Online]. Available: https://sid.ir/paper/42752/en

Related Journal Papers